MCLEAN, Va.--(BUSINESS WIRE)--Apr 22, 2021--
D2M, the outcome-driven service and solution partner that accelerates enterprises’ digital transformation journeys to meet their business goals, announces recent successes in their ongoing engagement with Ora, Inc..
A leader in the ophthalmic research space, Ora conducts pre-clinical and clinical drug and device development to offer relief to those with vision challenges. As Ora prepared for continuing growth, D2M’s expertise was valuable from the outset to help reinforce and build upon Ora’s global digital infrastructure. The initial transition of Ora’s assets to a new, customized cloud-based environment took D2M just two-months to complete, a significant decrease over the 6–12-month industry average.
“Security and availability of systems, as well as integrity of data, are critical to our industry and the customers we serve every day,” said Jack Crowley, Senior Vice President and Chief Financial Officer, Ora. “D2M worked alongside us as a true, collaborative partner. They immediately understood our needs and quickly and efficiently enhanced our infrastructure in preparation for ongoing growth. We look forward to additional possibilities as we deepen this partnership.”
The D2M and Ora teams will continue to work hand-in-hand going forward, with plans to further customize Ora’s IT infrastructure to align with its future needs and goals. The next steps in the teams’ future-forward digital transformation journey include implementations of several innovative, custom tools. These include new Service Desk tools, including self-service functionality; innovative Networking and Cyber Security features; and enhanced Cloud Management tools and approaches. These efforts will focus on maximizing productivity, reducing costs, and supporting continued dynamism in Ora’s ongoing transformation journey.
“D2M has delivered measurable results to date for Ora,” Rajiv Tandon, Vice President- Head of Business, D2M said. “Our outcome-based approach harnesses the power of established and emerging technologies. We worked with the Ora team to implement a scalable delivery model with built-in processes to increase efficiencies and improve service experiences, which will play a leading role as they continue to expand worldwide.”
For more than 25 years, D2M, as part of DISYS, has delivered measurable results for its enterprise and quasi-government clients by building custom implementations to meet clients’ individual IT needs. In conjunction with product innovators and thought leaders, D2M continues to surpass the boundaries of technology and objective-based innovation. D2M is headquartered in McLean, VA, with more than 45 offices worldwide. For more information about D2M, visit www.d2mservices.com.
About Ora®, Inc.
Ora is the world's leading full-service ophthalmic drug and device development firm with offices in the United States, United Kingdom, Australia, and Asia. For over 40 years, we have proudly helped our clients earn more than 45 product approvals. We support a wide array of organizations, from start-ups to global pharmaceutical and device companies, to efficiently bring their new products from concept to market. Ora's pre-clinical and clinical models, unique methodologies, and global regulatory strategies have been refined and proven across thousands of global projects. We bring together the world's most extensive and experienced team of ophthalmic experts, R&D professionals, and management executives to maximize the value of new product initiatives. For more information, please visit www.oraclinical.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20210422005213/en/
CONTACT: Sandra Schwartzman
Vice President of Public Relations
RMR & Associates
(301) 230 – 0045 x 100
KEYWORD: UNITED STATES NORTH AMERICA VIRGINIA
INDUSTRY KEYWORD: SOFTWARE TECHNOLOGY NETWORKS
Copyright Business Wire 2021.
PUB: 04/22/2021 09:47 AM/DISC: 04/22/2021 09:47 AM